Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT04316715

Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care

Conditions: Adherence, Medication

Sex: Male
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 300
Sponsor: University of Miami

Location: University of Miami Miami Florida

Summary

The purpose of this study is to test how different types of interventions may affect how someone takes their pre-exposure prophylaxis (PrEP) medication.

Eligibility Criteria

Inclusion Criteria: 1. Age: 18 years or older 2. Male sex at birth or trans man (current gender identity is male) assigned female sex at birth 3. Self-reports as a person who has sex with men 4. PrEP naïve or is currently prescribed PrEP and reports uncertainty about future adherence 5. Medical providers at each site will determine that the participant is indicated for PrEP per Centers for Disease Control (CDC) guidelines 6. Screens in for currently having one or more of the following psychosocial syndemic problems: depression; heavy alcohol use; problematic substance use or polydrug use; history of trauma or abuse; and/or current interpersonal violence 7. Owns a cell phone that has texting and internet / data capacity Exclusion Criteria: 1. Unable to provide informed consent due to severe mental or physical illness, cognitive impairment, or substance intoxication at the time of interview 2. Discovery of active suicidal ideation or major mental illness (e.g. untreated psychosis or mania) at the time of enrollment (these patients will be referred immediately for treatment, but may join the study when this is resolved) 3. Laboratory or clinical findings that would preclude PrEP initiation (e.g. decreased creatinine clearance)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04316715). StuddyBuddy aggregates publicly available trial information.